Education
About Us
Working with TipRanks
Follow Us
PreveCeutical Medical Inc (PRVCF)
OTHER OTC:PRVCF
Total Valuation
PreveCeutical Medical has a market cap or net worth of $10.66M. The enterprise value is $21.45M.
Market Cap$10.66M
Enterprise Value$21.45M
Share Statistics
PreveCeutical Medical has 586,811,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding586,811,950
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PreveCeutical Medical’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 37.33%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)37.33%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee0.00
Profits Per Employee-167.81K
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PreveCeutical Medical is ―. PreveCeutical Medical’s PEG ratio is 114.24.
PE Ratio―
PS Ratio0.00
PB Ratio-2.02
Price to Fair Value-2.02
Price to FCF-31.30
Price to Operating Cash Flow-20.00
PEG Ratio114.24
Income Statement
In the last 12 months, PreveCeutical Medical had revenue of 0.00 and earned -1.17K in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-10.10K
Operating Income-812.47K
Pretax Income-1.17M
Net Income-1.17K
EBITDA-837.46K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -1.25M and capital expenditures -60.72K, giving a free cash flow of -1.31M billion.
Operating Cash Flow-1.25M
Free Cash Flow-1.31M
Free Cash Flow per Share>-0.01
Dividends & Yields
PreveCeutical Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.96
52-Week Price Change-50.00%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)40.83
Average Volume (3m)90.41K
Important Dates
PreveCeutical Medical upcoming earnings date is May 6, 2026, After Close (Confirmed).
Last Earnings DateDec 1, 2025
Next Earnings DateMay 6, 2026
Ex-Dividend Date―
Financial Position
PreveCeutical Medical as a current ratio of 0.02, with Debt / Equity ratio of -63.16%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.33
Net Debt to EBITDA-5.26
Interest Coverage Ratio-2.48
Taxes
In the past 12 months, PreveCeutical Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PreveCeutical Medical EV to EBITDA ratio is -21.27, with an EV/FCF ratio of -41.57.
EV to Sales0.00
EV to EBITDA-21.27
EV to Free Cash Flow-41.57
EV to Operating Cash Flow-41.75
Balance Sheet
PreveCeutical Medical has $103.68K in cash and marketable securities with $4.60M in debt, giving a net cash position of -$4.49M billion.
Cash & Marketable Securities$103.68K
Total Debt$4.60M
Net Cash-$4.49M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PreveCeutical Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―